FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+10.33%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$20.6B
AUM Growth
+$395M
(+2%)
Cap. Flow
-$851M
Cap. Flow
% of AUM
-4.14%
Top 10 Holdings %
Top 10 Hldgs %
45.9%
Holding
486
New
42
Increased
157
Reduced
204
Closed
61
Top Buys
| 1 |
Applovin
APP
|
$291M |
| 2 |
Constellation Energy
CEG
|
$106M |
| 3 |
Apple
AAPL
|
$94.3M |
| 4 |
HubSpot
HUBS
|
$80.7M |
| 5 |
Amgen
AMGN
|
$57.2M |
Top Sells
| 1 |
Natera
NTRA
|
$139M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$116M |
| 3 |
Advanced Micro Devices
AMD
|
$95.5M |
| 4 |
NVIDIA
NVDA
|
$88M |
| 5 |
Mobileye
MBLY
|
$78.4M |
Sector Composition
| 1 | Technology | 41.28% |
| 2 | Healthcare | 15.45% |
| 3 | Communication Services | 13.11% |
| 4 | Consumer Discretionary | 10.67% |
| 5 | Industrials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Flex
FLEX
$20.8B
| $1.18M | 0.01% |
39,888
-2,674
| -6% | -$78.9K |
|
|
ITCI
352
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.13M | 0.01% |
16,564
+4,030
| +32% | +$276K |
|
353
Oric Pharmaceuticals
ORIC
$1.06B
| $1.1M | 0.01% |
155,912
-64,031
| -29% | -$453K |
|
354
Onto Innovation
ONTO
$5.1B
| $1.1M | 0.01% |
+5,003
| New | +$1.1M |
|
355
Codexis
CDXS
$218M
| $1.08M | 0.01% |
349,490
-158,605
| -31% | -$492K |
|
356
Digital Realty Trust
DLR
$55.7B
| $1.07M | 0.01% |
7,035
+3,273
| +87% | +$498K |
|
357
Accenture
ACN
$159B
| $1.04M | 0.01% |
3,413
+94
| +3% | +$28.5K |
|
358
Forte Biosciences
FBRX
$140M
| $988K | ﹤0.01% |
73,559
| – | – |
|
359
The Ensign Group
ENSG
$10B
| $908K | ﹤0.01% |
+7,342
| New | +$908K |
|
360
Revolution Medicines
RVMD
$7.57B
| $845K | ﹤0.01% |
+21,764
| New | +$845K |
|
361
Pinduoduo
PDD
$177B
| $804K | ﹤0.01% |
6,047
+1,630
| +37% | +$217K |
|
362
Nurix Therapeutics
NRIX
$758M
| $794K | ﹤0.01% |
+38,066
| New | +$794K |
|
363
First Solar
FSLR
$22B
| $787K | ﹤0.01% |
3,491
+635
| +22% | +$143K |
|
364
Zoetis
ZTS
$67.9B
| $689K | ﹤0.01% |
3,973
-511
| -11% | -$88.6K |
|
365
Autodesk
ADSK
$69.5B
| $646K | ﹤0.01% |
2,612
-572
| -18% | -$142K |
|
366
PTC
PTC
$25.6B
| $639K | ﹤0.01% |
3,516
+266
| +8% | +$48.3K |
|
367
Avidity Biosciences
RNA
$6.48B
| $638K | ﹤0.01% |
+15,625
| New | +$638K |
|
368
Denali Therapeutics
DNLI
$2.26B
| $627K | ﹤0.01% |
+27,014
| New | +$627K |
|
369
Xylem
XYL
$34.2B
| $600K | ﹤0.01% |
4,421
| – | – |
|
370
Agilent Technologies
A
$36.5B
| $599K | ﹤0.01% |
4,624
| – | – |
|
371
Saia
SAIA
$8.34B
| $551K | ﹤0.01% |
1,162
-342
| -23% | -$162K |
|
372
Quanterix
QTRX
$211M
| $535K | ﹤0.01% |
40,495
-603
| -1% | -$7.97K |
|
373
Deere & Co
DE
$128B
| $509K | ﹤0.01% |
1,362
| – | – |
|
374
Roper Technologies
ROP
$55.8B
| $504K | ﹤0.01% |
894
| – | – |
|
375
Arcos Dorados Holdings
ARCO
$1.47B
| $474K | ﹤0.01% |
52,704
-168,827
| -76% | -$1.52M |
|